Pancreatic Cancer Research

ResearcherGuiyang Medical UniversityActive in the last 2 years

Yaozhen Pan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9300-382X; OpenAlex author ID A5024683886. Sources: OpenAlex.

Their work

Papers
15 (first author 1, last author 11)
Trials
0
Grants
0
Labs led
1
Collaborators
24
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: 1 paper · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: none · 2022: 1 paper · 2023: 4 papers · 2024: 4 papers · 2025: 2 papers

Papers 15

  1. DTL promotes pancreatic cancer progression through ubiquitin-mediated degradation of SMAD4. Last author DOI 10.1016/j.ijbiomac.2025.148692↗
  2. An analysis of the global burden of pancreatic cancer attributable to High fasting plasma glucose: 1990– 2021 Last author DOI 10.21203/rs.3.rs-7063506/v1↗
  3. Unveiling the role of PYGB in pancreatic cancer: a novel diagnostic biomarker and gene therapy target. Last author DOI 10.1007/s00432-024-05644-2↗
  4. TAGLN2 targeted control of ARPC5-mediated activation of the MEK/ERK signaling pathway influences the proliferation, invasion, and metastasis of pancreatic canc… Last author DOI 10.1016/j.cellsig.2024.111227↗
  5. PELI1: key players in the oncogenic characteristics of pancreatic Cancer. Last author DOI 10.1186/s13046-024-03008-9↗
  6. A study on the role of Taxifolin in inducing apoptosis of pancreatic cancer cells: screening results using weighted gene co-expression network analysis. Last author DOI 10.18632/aging.205500↗
  7. FBXO28 promotes proliferation, invasion, and metastasis of pancreatic cancer cells through regulation of SMARCC2 ubiquitination. Last author DOI 10.18632/aging.204780↗
  8. Correction for: FBXO28 promotes proliferation, invasion, and metastasis of pancreatic cancer cells through regulation of SMARCC2 ubiquitination. Last author DOI 10.18632/aging.205071↗
  9. The deubiquitinating enzyme MINDY2 promotes pancreatic cancer proliferation and metastasis by stabilizing ACTN4 expression and activating the PI3K/AKT/mTOR sig… Last author DOI 10.3389/fonc.2023.1169833↗
  10. Analysis and validation of the potential of the MYO1E gene in pancreatic adenocarcinoma based on a bioinformatics approach. Last author DOI 10.3892/ol.2023.13871↗
  11. FAM126A interacted with ENO1 mediates proliferation and metastasis in pancreatic cancer via PI3K/AKT signaling pathway. Last author DOI 10.1038/s41420-022-01047-9↗
  12. LAMB3 mediates apoptotic, proliferative, invasive, and metastatic behaviors in pancreatic cancer by regulating the PI3K/Akt signaling pathway. First author DOI 10.1038/s41419-019-1320-z↗
  13. MiR-1297 suppresses pancreatic cancer cell proliferation and metastasis by targeting MTDH. Co-author DOI 10.1016/j.mcp.2018.06.003↗
  14. Telomerase activity as a marker for differential diagnosis of pancreatic adenocarcinoma: a systematic review and meta-analysis. Co-author DOI 10.5301/jbm.5000172↗
  15. KAP-1 is overexpressed and correlates with increased metastatic ability and tumorigenicity in pancreatic cancer. Co-author DOI 10.1007/s12032-014-0025-5↗

Closest collaborators

The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Xiaobin Fei · 8 shared papers, 2023–2024 · strength 1.62
  2. Songbai Liu · 7 shared papers, 2022–2024 · strength 1.32
  3. Likun Ren · 5 shared papers, 2024–2025 · strength 1.13
  4. Peng Liu · 4 shared papers, 2022–2024 · strength 0.78
  5. Shaojie Chen · 3 shared papers, 2024–2025 · strength 0.71
  6. Zhiwei He · 3 shared papers, 2019–2023 · strength 0.44
  7. Xing Wang · 2 shared papers, 2024 · strength 0.42
  8. Yongjia Gao · 2 shared papers, 2024 · strength 0.42
  9. Li Siyuan · 1 shared paper, 2025 · strength 0.33
  10. Xi-zhuang Pan · 1 shared paper, 2025 · strength 0.25
  11. Chao Yu · 3 shared papers, 2014–2019 · strength 0.23
  12. Chengyi Sun · 2 shared papers, 2018–2019 · strength 0.19
  13. Peng Liu · 1 shared paper, 2023 · strength 0.18
  14. Yongning Li · 1 shared paper, 2022 · strength 0.17
  15. Zili Chen · 1 shared paper, 2018 · strength 0.10
  16. Haitao Zhu · 1 shared paper, 2018 · strength 0.10
  17. Hong Zhang · 1 shared paper, 2019 · strength 0.10
  18. She Tian · 1 shared paper, 2016 · strength 0.07
  19. Chengyi Sun · 1 shared paper, 2016 · strength 0.07
  20. Huajian Gu · 1 shared paper, 2016 · strength 0.07
  21. Chenyi Sun · 1 shared paper, 2014 · strength 0.04
  22. Min Wang · 1 shared paper, 2014 · strength 0.04
  23. Jianxin Jiang · 1 shared paper, 2014 · strength 0.04
  24. Renyi Qin · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.